Pelish Henry E. 4

What Happened Henry E. Pelish, Chief Scientific Officer of Nuvalent, reported an open-market sale of 2,111 shares on July 9, 2026. The shares were sold at $123.81 per share, generating gross proceeds of approximately $261,363. This transaction is coded as a sale (S) and was executed to cover taxes related to previously granted equity awards.

Key Details

• Transaction date: 2026-07-09; Sale price: $123.81 per share; Shares sold: 2,111; Proceeds: ~$261,363.
• Shares owned after the transaction: not specified in the filing.
• Footnote: Sale effected pursuant to a durable Rule 10b5-1 sell-to-cover instruction entered Dec 6, 2023 to satisfy tax withholding on vested awards.
• Filing date: 2026-07-10 (filed the business day after the transaction), so appears timely.

Context This was a routine sell-to-cover under a pre-existing 10b5-1 plan to satisfy tax obligations from vested equity, not an open-ended directional trade. Such tax-withholding sales are common and do not necessarily indicate the insider's view on the company's prospects.